392 related articles for article (PubMed ID: 32743775)
1. An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance.
Alipoor B; Parvar SN; Sabati Z; Ghaedi H; Ghasemi H
Mol Biol Rep; 2020 Aug; 47(8):6357-6374. PubMed ID: 32743775
[TBL] [Abstract][Full Text] [Related]
2. The double-edged sword of H19 lncRNA: Insights into cancer therapy.
Shermane Lim YW; Xiang X; Garg M; Le MT; Li-Ann Wong A; Wang L; Goh BC
Cancer Lett; 2021 Mar; 500():253-262. PubMed ID: 33221454
[TBL] [Abstract][Full Text] [Related]
3. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
[TBL] [Abstract][Full Text] [Related]
4. Expression and role of long non-coding RNA H19 in carcinogenesis.
Yoshimura H; Matsuda Y; Yamamoto M; Kamiya S; Ishiwata T
Front Biosci (Landmark Ed); 2018 Jan; 23(4):614-625. PubMed ID: 28930564
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA H19: a potential biomarker and therapeutic target in human malignant tumors.
Zhang R; Zeng Y; Deng JL
Clin Exp Med; 2023 Sep; 23(5):1425-1440. PubMed ID: 36484927
[TBL] [Abstract][Full Text] [Related]
6. MiRNA-200c, MiRNA-139 and ln RNA H19; new predictors of treatment response in H-pylori- induced gastric ulcer or progression to gastric cancer.
Schaalan M; Mohamed W; Fathy S
Microb Pathog; 2020 Dec; 149():104442. PubMed ID: 32795593
[TBL] [Abstract][Full Text] [Related]
7. The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications.
Vennin C; Spruyt N; Robin YM; Chassat T; Le Bourhis X; Adriaenssens E
Cancer Lett; 2017 Jan; 385():198-206. PubMed ID: 27780718
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy.
Hashemi M; Moosavi MS; Abed HM; Dehghani M; Aalipour M; Heydari EA; Behroozaghdam M; Entezari M; Salimimoghadam S; Gunduz ES; Taheriazam A; Mirzaei S; Samarghandian S
Pharmacol Res; 2022 Oct; 184():106418. PubMed ID: 36038043
[TBL] [Abstract][Full Text] [Related]
9. H19 lncRNA: Roles in tumorigenesis.
Ghafouri-Fard S; Esmaeili M; Taheri M
Biomed Pharmacother; 2020 Mar; 123():109774. PubMed ID: 31855739
[TBL] [Abstract][Full Text] [Related]
10. Critical roles of long noncoding RNA H19 in cancer.
Darmadi D; Chugaeva UY; Saleh RO; Hjazi A; Saleem HM; Ghildiyal P; Alwaily ER; Alawadi A; Alnajar MJ; Ihsan A
Cell Biochem Funct; 2024 Apr; 42(3):e4018. PubMed ID: 38644608
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA H19 can predict a poor prognosis and lymph node metastasis: a meta-analysis in human cancer.
Chen T; Yang P; He ZY
Minerva Med; 2016 Aug; 107(4):251-8. PubMed ID: 27348443
[TBL] [Abstract][Full Text] [Related]
12. Taurine-upregulated gene 1 contributes to cancers through sponging microRNA.
Zhou H; Gao Z; Wan F
Acta Biochim Biophys Sin (Shanghai); 2019 Feb; 51(2):123-130. PubMed ID: 30590378
[TBL] [Abstract][Full Text] [Related]
13. The miRNA hsa-miR-6515-3p potentially contributes to lncRNA H19-mediated-lung cancer metastasis.
Xu Y; Lin J; Jin Y; Chen M; Zheng H; Feng J
J Cell Biochem; 2019 Oct; 120(10):17413-17421. PubMed ID: 31131469
[TBL] [Abstract][Full Text] [Related]
14. Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer.
Zhou H; Shen W; Zou H; Lv Q; Shao P
J Int Med Res; 2020 Jul; 48(7):300060520934297. PubMed ID: 32660285
[TBL] [Abstract][Full Text] [Related]
15. The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision.
Matouk IJ; Halle D; Raveh E; Gilon M; Sorin V; Hochberg A
Oncotarget; 2016 Jan; 7(4):3748-65. PubMed ID: 26623562
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of lncRNA H19 sensitizes melanoma cells to cisplatin by regulating the miR-18b/IGF1 axis.
An LF; Huang JW; Han X; Wang J
Anticancer Drugs; 2020 Jun; 31(5):473-482. PubMed ID: 32265386
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152.
Li Z; Li Y; Li Y; Ren K; Li X; Han X; Wang J
J Biochem Mol Toxicol; 2017 Sep; 31(9):. PubMed ID: 28544374
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA H19 and cancer: A competing endogenous RNA.
Ye Y; Shen A; Liu A
Bull Cancer; 2019 Dec; 106(12):1152-1159. PubMed ID: 31753509
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer.
Wang SH; Ma F; Tang ZH; Wu XC; Cai Q; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
J Exp Clin Cancer Res; 2016 Oct; 35(1):160. PubMed ID: 27716361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
